Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Emerging treatments in type 2 diabetes: focus on canagliflozin

Total article views   Abstract views HTML views PDF downloads Totals
9,073 Dovepress* 5,691 1,395+ 2,103 7,086
PubMed Central* 0 1,987 910 1,987
Totals 5,691 3,382 3,013 9,073
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar